Brain

Hyperfine, Inc. to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared…

4 weeks ago

PreveCeutical Provides Clarification of News Release Announcing Update on Plan of Arrangement with BioGene Therapeutics Inc.

Vancouver, British Columbia--(Newsfile Corp. - November 20, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"),…

4 weeks ago

Voio Emerges From Stealth to Build Frontier AI for Healthcare

Voio team’s initial open-source release, Pillar-0, is the world’s most accurate AI model for radiology and builds on the success…

4 weeks ago

Voio Emerges From Stealth to Build Frontier AI for Healthcare

Voio team’s initial open-source release, Pillar-0, is the world’s most accurate AI model for radiology and builds on the success…

4 weeks ago

Oxford-Harrington Rare Disease Centre Announces 2025 Scholars Advancing Promising Treatments

Ten scientists selected for second annual award to pursue innovations in gene, RNA, small molecule and cell therapies to treat…

4 weeks ago

CABHI launches novel Brain Bases to drive the global brain economy

TORONTO, Nov. 20, 2025 /CNW/ - The Centre for Aging + Brain Health Innovation (CABHI), powered by Baycrest, has launched…

4 weeks ago

Fluents.ai voice AI Introduces “Continuous Context” Omnichannel Platform to End the Era of Disjointed Customer Service

SAN FRANCISCO, Nov. 20, 2025 /PRNewswire/ -- Fluents.ai today announced the launch of Fluents Omnichannel, a unified AI architecture designed…

4 weeks ago

Bracco Imaging Achieves New Global Milestone with ANVISA Clearance of AiMIFY™ in Brazil

Regulatory Approval Expands Access to AI-Powered Diagnostics Across Latin America, Following FDA and CE Mark Clearances MILAN, Nov. 20, 2025 /PRNewswire/…

4 weeks ago

Revelation Biosciences On Track for End-of-Phase 1 Meeting With FDA Later This Year

SAN DIEGO, CA / ACCESS Newswire / November 20, 2025 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a…

4 weeks ago

Revelation Biosciences On Track for End-of-Phase 1 Meeting With FDA Later This Year

SAN DIEGO, CA / ACCESS Newswire / November 20, 2025 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a…

4 weeks ago